These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18312830)

  • 1. Difference in brain distributions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel.
    Fuchigami T; Haradahira T; Fujimoto N; Okauchi T; Maeda J; Suzuki K; Suhara T; Yamamoto F; Sasaki S; Mukai T; Yamaguchi H; Ogawa M; Magata Y; Maeda M
    Nucl Med Biol; 2008 Feb; 35(2):203-12. PubMed ID: 18312830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors.
    Fuchigami T; Haradahira T; Fujimoto N; Nojiri Y; Mukai T; Yamamoto F; Okauchi T; Maeda J; Suzuki K; Suhara T; Yamaguchi H; Ogawa M; Magata Y; Maeda M
    Bioorg Med Chem; 2009 Aug; 17(15):5665-75. PubMed ID: 19586774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.
    Matsumoto R; Haradahira T; Ito H; Fujimura Y; Seki C; Ikoma Y; Maeda J; Arakawa R; Takano A; Takahashi H; Higuchi M; Suzuki K; Fukui K; Suhara T
    Synapse; 2007 Oct; 61(10):795-800. PubMed ID: 17598152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endogenous agonists, glycine and D-serine, on in vivo specific binding of [11C]L-703,717, a PET radioligand for the glycine-binding site of NMDA receptors.
    Haradahira T; Okauchi T; Maeda J; Zhang MR; Nishikawa T; Konno R; Suzuki K; Suhara T
    Synapse; 2003 Nov; 50(2):130-6. PubMed ID: 12923815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A positron-emitter labeled glycine(B) site antagonist, [(11)C]L-703,717, preferentially binds to a cerebellar NMDA receptor subtype consisting of GluR epsilon3 subunit in vivo, but not in vitro.
    Haradahira T; Okauchi T; Maeda J; Zhang MR; Kida T; Kawabe K; Mishina M; Watanabe Y; Suzuki K; Suhara T
    Synapse; 2002 Feb; 43(2):131-3. PubMed ID: 11754492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prodrug of NMDA/glycine site antagonist, L-703,717, with improved BBB permeability: 4-acetoxy derivative and its positron-emitter labeled analog.
    Haradahira T; Zhang MR; Maeda J; Okauchi T; Kida T; Kawabe K; Sasaki S; Suhara T; Suzuki K
    Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):147-50. PubMed ID: 11217099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxy-phenyl)-N'-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor.
    Waterhouse RN; Slifstein M; Dumont F; Zhao J; Chang RC; Sudo Y; Sultana A; Balter A; Laruelle M
    Nucl Med Biol; 2004 Oct; 31(7):939-48. PubMed ID: 15464396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of [11C]-3-[2-[(3-methoxyphenylamino)carbonyl]ethenyl]-4,6-dichloroindole-2-carboxylic acid ([11C]3MPICA) as a PET radiotracer for the glycine site of the NMDA ion channel.
    Waterhouse RN; Sultana A; Laruelle M
    Nucl Med Biol; 2002 Nov; 29(8):791-4. PubMed ID: 12453587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding characterization of N-(2-chloro-5-thiomethylphenyl)-N'-(3-[
    Metaxas A; van Berckel BNM; Klein PJ; Verbeek J; Nash EC; Kooijman EJM; Renjaän VA; Golla SSV; Boellaard R; Christiaans JAM; Windhorst AD; Leysen JE
    Pharmacol Res Perspect; 2019 Feb; 7(1):e00458. PubMed ID: 30784206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.
    Guzikowski AP; Cai SX; Espitia SA; Hawkinson JE; Huettner JE; Nogales DF; Tran M; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Nov; 39(23):4643-53. PubMed ID: 8917653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (+/-)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors.
    Haradahira T; Maeda J; Okauchi T; Zhang MR; Hojo J; Kida T; Arai T; Yamamoto F; Sasaki S; Maeda M; Suzuki K; Suhara T
    Nucl Med Biol; 2002 Jul; 29(5):517-25. PubMed ID: 12088721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and initial PET imaging of new potential dopamine D3 receptor radioligands (E)-4,3,2-[11C]methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides.
    Gao M; Mock BH; Hutchins GD; Zheng QH
    Bioorg Med Chem; 2005 Nov; 13(22):6233-43. PubMed ID: 16087340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosynthesis and pharmacological evaluation of [11C]EMD-95885: a high affinity ligand for NR2B-containing NMDA receptors.
    Roger G; Dollé F; De Bruin B; Liu X; Besret L; Bramoullé Y; Coulon C; Ottaviani M; Bottlaender M; Valette H; Kassiou M
    Bioorg Med Chem; 2004 Jun; 12(12):3229-37. PubMed ID: 15158791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro and in vivo evaluation of [11C]methyl-BIII277CL for imaging the PCP-binding site of the NMDA receptor by pet.
    Kokic M; Honer M; Kessler LJ; Grauert M; Schubiger PA; Ametamey SM
    J Recept Signal Transduct Res; 2002; 22(1-4):123-39. PubMed ID: 12503611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of [3H]CNS-5161--a use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain.
    Biegon A; Gibbs A; Alvarado M; Ono M; Taylor S
    Synapse; 2007 Aug; 61(8):577-86. PubMed ID: 17455246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.
    Rowley M; Kulagowski JJ; Watt AP; Rathbone D; Stevenson GI; Carling RW; Baker R; Marshall GR; Kemp JA; Foster AC; Grimwood S; Hargreaves R; Hurley C; Saywell KL; Tricklebank MD; Leeson PD
    J Med Chem; 1997 Dec; 40(25):4053-68. PubMed ID: 9406596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site.
    Baron BM; Siegel BW; Harrison BL; Gross RS; Hawes C; Towers P
    J Pharmacol Exp Ther; 1996 Oct; 279(1):62-8. PubMed ID: 8858976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 18F-FA-4 and 11C-pipzA-4 as radioligands for the in vivo evaluation of the high-affinity choline uptake system.
    Gilissen C; de Groot TJ; Bronfman F; van Leuven F; Verbruggen AM; Bormans GM
    J Nucl Med; 2003 Feb; 44(2):269-75. PubMed ID: 12571220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioligand binding assays for the glycine site on N-methyl-D-aspartate receptors.
    Perschke S; Ferkany J
    Curr Protoc Pharmacol; 2002 Aug; Chapter 1():Unit 1.27. PubMed ID: 22294074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.